At day 15, DR500 tumor cells induced changes similar to those induced by MR20 cells (decrease in Gr1+D11b+ cells, increased in CD4+, CD8+ T and B lymphocytes) at the three sites, but to a lesser extent. The gene discussed is CD4; the disease is neoplasm.